2013-03-15T10:10:00-05:00 2012-06-30 911194016 CLARK NUBER PS 10900 NE 4TH STREET SUITE 1700 BELLEVUE WA 98004 990 2011-07-01 911935159 SEATTLE CANCER CARE ALLIANCE SEAT 2062881000 825 EASTLAKE AVENUE EAST PO BOX 19023 SEATTLE WA 981091023 JONATHAN TINGSTAD 2062881000 2013-03-15 1 SARA ELIZABETH J HYRE P00235495 4254544919 2011 2016-02-25 16:41:14Z FRED APPELBAUM MD 1100 FAIRVIEW AVE N SEATTLE WA 98109 522771791 0 X WWW.SEATTLECCA.ORG X 1998 WA SEATTLE CANCER CARE ALLIANCE (SCCA) IS A WORLD-CLASS CANCER TREATMENT CENTER (SEE SCHEDULE O) THAT UNITES THE DOCTORS FROM FRED HUTCHINSON CANCER RESEARCH CENTER, UW MEDICINE, AND SEATTLE CHILDREN'S. OUR GOAL, EVERY DAY, IS TO TURN CANCER PATIENTS INTO CANCER SURVIVORS. OUR VISION IS TO LEAD THE WORLD IN TRANSLATING SCIENTIFIC DISCOVERY INTO THE PREVENTION, DIAGNOSIS, TREATMENT, AND CURE OF CANCER. 18 18 1284 261 37 0 8779628 2564192 318736590 348949857 5409272 6617931 29158 -47698 332954648 358084282 1122767 935916 0 0 79761116 88365958 0 0 33141 220781365 238605331 301665248 327907205 31289400 30177077 404530310 415596706 160392342 153584769 244137968 262011937 X SEATTLE CANCER CARE ALLIANCE UNITES THE DOCTORS FROM FRED HUTCHINSON CANCER RESEARCH CENTER, UW MEDICINE, AND SEATTLE CHILDREN'S. OUR GOAL IS TO TURN CANCER PATIENTS INTO CANCER SURVIVORS. OUR PURPOSE IS TO LEAD THE WORLD IN THE PREVENTION AND TREATMENT OF (SEE SCHEDULE O) CANCER. WITH OUR PARENT ORGANIZATIONS, SCCA IS HOME TO THE WORLD'S BEST SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, PATHOLOGISTS, AND RADIOLOGISTS. PATIENTS RECEIVE THE LATEST TAILORED COURSE OF TREATMENTS AND THERAPIES FOR CANCER AND HAVE ACCESS TO NEW DRUGS AND TREATMENTS THAT ARE UNDER INVESTIGATION IN CLINICAL STUDIES AVAILABLE AT SCCA AND LIMITED SITES AROUND THE COUNTRY. FHCRC, WITH ITS PARTNERS UW MEDICINE, SEATTLE CHILDREN'S, AND SCCA COMPRISE THE FRED HUTCHINSON/UW CANCER CONSORTIUM. THE CONSORTIUM IS ONE OF 40 COMPREHENSIVE CANCER CENTERS DESIGNATED BY THE NATIONAL CANCER INSTITUTE (NCI) AND HAS RECEIVED MORE FUNDING FOR CANCER RESEARCH THAN ANY OTHER NCI SITE IN THE COUNTRY. 0 0 245215162 830796 347221740 SCCA'S FOCUS IS TO SPEED UP THE TRANSFER OF NEW DIAGNOSTIC AND TREATMENT TECHNIQUES FROM THE RESEARCH SETTING TO PATIENT CARE. THE HIGHLY INTEGRATED APPROACH TO CANCER RESEARCH AND TREATMENT AMONG SCCA PARTNER ORGANIZATIONS SUPPORTS THE FLOW OF SCIENTIFIC INFORMATION AMONG RESEARCHERS, CLINICIANS, AND PATIENTS, THEREBY ACCELERATING THE DEVELOPMENT OF NEW KNOWLEDGE AND TREATMENT OF VARIOUS CANCERS. DURING THE YEAR ENDED JUNE 30, 2012, SCCA TREATED 5,595 NEW PATIENTS WITHIN THE CANCER AND BONE MARROW/STEM CELL TRANSPLANT PROGRAMS. SCCA ALSO HAD 72,300 CLINIC VISITS, 83,554 INFUSION HOURS, 13,725 RADIATION ONCOLOGY TREATMENTS, AND PERFORMED 44,225 IMAGING SCANS. 2785201 105120 1728117 SEATTLE CANCER CARE ALLIANCE HOUSE IS A TEMPORARY MEDICAL HOUSING FACILITY. IT IS AN 80-ROOM FACILITY THAT PROVIDES AN AFFORDABLE HOME FOR CANCER PATIENTS AND THEIR FAMILIES WHO COME TO SEATTLE FOR EXTENDED TREATMENT WITH SCCA. THE SIX-STORY "BUILT GREEN" BUILDING WAS DESIGNED TO ADDRESS PATIENTS' PHYSICIAL, EMOTIONAL, AND LOGISTICAL CHALLENGES. SCCA HOUSE IS LOCATED VERY CLOSE TO THE SCCA OUTPATIENT CLINIC AND OFFERS SHUTTLE SERVICE TO THE SCCA CLINIC. THE SCCA HOUSE OFFERS PATIENTS A HOME AWAY FROM HOME WITH WELLNESS AND EXERCISE ROOMS, IN ROOM KITCHENETTES, A LARGE COMMON KITCHEN AND DINING ROOM, RESOURCE CENTER AND LIBRARY, THEATER, EXERCISE ROOM, IN-ROOM, SEPARATE CAREGIVER SLEEPING AREAS, FREE LAUNDRY 24 HRS/DAY, FREE WIRELESS INTERNET ACCESS, SECURE BUILDING, GARAGE AND PARKING, INFECTION CONTROL MEASURES, AS WELL AS A ROOFTOP GARDEN. THE COMMON AREAS SERVE AS MEETING CENTERS FOR OUR COMMUNITY PARTNERS. SCCA HOUSE IS AN EXAMPLE OF SCCA'S COMMITTMENT TO THE MISSION OF PROVIDING FAMILY CENTERED PATIENT CARE. 248000363 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 1 148 0 1 1284 1 0 0 0 0 0 0 0 0 0 0 X 18 18 1 0 0 0 1 1 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 0 AL AK AZ AR CO CT FL HI IL KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X JONATHAN TINGSTAD 2062881058 825 EASTLAKE AVENUE EAST PO BOX SEATTLE WA 98109 BROOKS RAGEN 8.00 X X 0 0 0 ROBB BAKEMEIER 6.00 X X 0 0 0 CARL BEHNKE 5.00 X X 0 0 0 BOB GERTH 5.00 X X 0 0 0 MARK GROUDINE MD PHD 1.50 X 0 0 0 PAT HAGAN 1.50 X 0 0 0 LISA BRANDENBURG 2.00 X 0 0 0 JONELLE JOHNSON 3.00 X 0 0 0 RICH JONES 3.00 X 0 0 0 ROB MACAULAY 3.00 X 0 0 0 RUTH MAHAN 2.00 X 0 0 0 LINDA MATTOX 1.00 X 0 0 0 RICH MCCUNE 2.00 X 0 0 0 KIMBERLY MCNALLY 2.00 X 0 0 0 SHAN MULLIN 2.50 X 0 0 0 KATHY RANDALL 2.00 X 0 0 0 JOHNESE SPISSO 1.50 X 0 0 0 BRUDER STAPLETON MD 1.00 X 0 0 0 MYRA TANITA 2.00 X 0 0 0 FRED APPELBAUM MD 9.00 X 312533 0 0 NORMAN HUBBARD 55.00 X 497015 0 47052 MADELINE BUELT 55.00 X 351011 0 52805 F MARC STEWART MD 20.00 X 274720 0 0 JONATHAN TINGSTAD 55.00 X 394532 0 52814 DEBORAH GENTZEN 55.00 X 258113 0 44480 DAVID ACKERSON 55.00 X 232121 0 33290 CHERYL WYMAN 55.00 X 208064 0 34668 GRETCHEN HANNA 55.00 X 206634 0 26482 JOSEPH NORTON 55.00 X 203243 0 40394 ZAKARIA RAMADAN-JRADI 55.00 X 197644 0 39107 ALEANA WAITE 55.00 X 186815 0 33183 DEBORAH STENHJEM 55.00 X 174505 0 31703 KRISTINE LOGAN 55.00 X 164835 0 24045 SUSAN HAMMOND 55.00 X 163603 0 16078 MOREEN DUDLEY 55.00 X 154056 0 27445 ALPHONSO EMERY 55.00 X 154042 0 21462 MARGARET OWENS 55.00 X 160214 0 18048 LINDA LAKE 55.00 X 147472 0 14890 BARBARA JAGELS 55.00 X 145374 0 32635 MICHELLE HALL 55.00 X 143568 0 27635 SHARI MCCLURE 55.00 X 141643 0 19748 4871757 0 637964 73 0 1 1 UNIVERITY OF WASHINGTON 1959 NE 59TH AVE SUITE 1005 SEATTLE WA 98104 HEALTHCARE, SERVICES, SUPPLIES, ADMIN 151808808 FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 ADMIN, SUPPORT, & SERVICES CONSULTING 18580545 SEATTLE CHILDRENS HOSPITAL PO BOX 50020 SEATTLE WA 98145 HEALTHCARE SERVICES 10975428 NATIONAL MARROW DONOR PROGRAM 3001 BROADWAY ST NE 500 MINNEAPOLIS MN 55413 MARROW TRANSPLANT SERVICES 8558513 PUGET SOUND BLOOD CENTER 921 TERRY AVENUE SEATTLE WA 98104 BLOOD & TISSUE SERVICES 4848723 93 290510 1149750 1123932 289426 2564192 CANCER HOSP/OUTPATIENT 621400 262899940 262470855 429085 MEDICARE/MEDICAID PMTS 900099 83839921 83839921 PATIENT HOUSING 900099 1728117 1728117 INTERAFFILIATE AGMTS 900099 481879 481879 348949857 4640004 37 4639967 6 6 166235561 27151 164140853 143938 2094708 -116787 1977921 1977921 290437 402718 -112281 -112281 EDUCATIONAL EVENTS 923110 64583 64583 64583 358084282 348585355 37 6934698 274442 274442 661474 661474 5185367 572764 4612603 64538638 41537671 23000967 3615245 2382903 1232342 9404937 5846871 3558066 5621771 3422532 2199239 42746769 21487669 21237164 21936 891880 891880 344580 344580 185130 185130 418947 418947 64653432 62635531 2017901 2936737 2906352 19180 11205 83919338 80968541 2950797 3028808 131122 2897686 166372 166372 5574647 1158526 4416121 360710 81240 279470 967345 43138 924207 6504748 6504748 14616026 6901313 7714713 592505 356202 236303 BUSINESS TAXES 6724093 6575150 148943 BAD DEBT 3323794 3323794 DUES & SUBSCRIPTIONS 350204 19400 330804 MISCELLANEOUS 299266 42608 256658 327907205 248000363 79873701 33141 13543965 17185944 64455064 41155383 1149750 55740367 44670511 3075374 3747462 2455474 2460962 191656305 80305714 109616611 111350591 105392201 156877068 29500000 15962218 14769832 13528728 5981422 7508089 404530310 415596706 54655069 49455575 455 866 105736818 104128328 160392342 153584769 X 242403683 260154225 833920 972123 900365 885589 244137968 262011937 404530310 415596706 X 30177077 -12303108 X 0 1 1 X 1 1 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 115285 0 1 69845 185130 0 EXPLANATION OF LOBBYING ACTIVITIES: PART II-B, LINE 1: LINE 1G: COMPENSATION PAID TO A HIRED LOBBYIST. LINE 1I: FRED HUTCHINSON CANCER RESEARCH CENTER GOVERNMENT AFFAIRS OFFICES WORK WITH LOCAL AND NATIONAL GOVERNMENTS FOR ISSUES FACING SEATTLE CANCER CARE ALLIANCE. AMOUNT EXPENDED = $21,336 LINE 1I: WASHINGTON STATE HOSPITAL ASSOCIATION REPRESENTS MEMBER INTERESTS ON THE LOCAL AND STATE LEVEL. THIS AMOUNT REFLECTS DUES ALLOCATED TO LEGISLATIVE EFFORTS = $33,509 LINE 1I: ASSOCIATION OF DEDICATED CANCER CENTERS REPRESENTS MEMBER INTERESTS AT THE NATIONAL LEVEL. AMOUNT EXPENDED = $15,000 900365 14776 885589 800371 112671 12677 900365 757066 43305 800371 885589 -128523 757066 1.00000 1 0 2217938 2217938 118875005 37583267 81291738 2594928 971976 1622952 48728576 33373747 15354829 19239858 8376724 10863134 111350591 358084282 327907205 30177077 1264055 -13567163 -12303108 17873969 342466000 1264055 31744 -16712534 -15416735 357882735 201547 201547 358084282 324715712 31744 519416 551160 324164552 418857 3323796 3742653 327907205 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: INCOME FROM PERMANENTLY RESTRICTED ENDOWMENT FUNDS IS USED FOR THE PURPOSE OF PROVIDING UNCOMPENSATED PATIENT CARE. DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: SCCA HAS OBTAINED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE INDICATING THAT IT IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE, EXCEPT FOR UNRELATED BUSINESS INCOME TAX. SCCAH ALSO OBTAINED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE INDICATING THAT IT IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE FOR FISCAL YEAR 2010, EXCEPT FOR UNRELATED BUSINESS INCOME TAX. SCCAH CEASED TO EXIST IN FISCAL YEAR 2011 AS A SEPARATE CORPORATE ENTITY. SCCA RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED. CHANGES IN RECOGNITION OR MEASUREMENT ARE REFLECTED IN THE PERIOD IN WHICH THE CHANGE IN JUDGMENT OCCURS. PART XI, LINE 8 - OTHER ADJUSTMENTS: PROCURE SEATTLE HOLDINGS, LLC - CHANGE IN VALUE -13,537,782. IMPAIRMENT LOSSES -29,469. ROUNDING 35. PROCURE SEATTLE HOLDINGS, LLC K-1 53. TOTAL TO SCHEDULE D, PART XI, LINE 8: -13,567,163. PART XII, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT EXPENSE -3,323,794. CHANGE IN VALUE OF INVESTMENTS - PROCURE SEATTLE HOLDINGS, LLC -13,537,782. IMPAIRMENT LOSS -29,469. RESTRICTED REVENUES RELEASED 597,620. INVESTMENT EXPENSES -418,857. ROUNDING -252. PART XII, LINE 4B - OTHER ADJUSTMENTS: K-1 INCOME FROM PROCURE SEATTLE HOLDINGS, LLC 37. GAIN/LOSS DISPOSAL OF FIXED ASSETS -116,787. COST OF GOODS SOLD REPORTED ON PART VIII -402,718. RESTRICTED REVENUES RELEASED 728,531. UNREALIZED GAINS ON TEMP RESTRICTED ASSETS 7,260. UNREALIZED GAINS ON PERM RESTRICTED ASSETS -14,776. PART XIII, LINE 2D - OTHER ADJUSTMENTS: GAIN/LOSS ON DISPOSAL OF FIXED ASSETS 116,788. COST OF GOODS SOLD REPORTED ON PART VIII 402,718. ADJUSTMENT DUE TO EQUITY METHOD USED FOR PROCURE SEATTLE HOLDINGS, LLC -90. PART XIII, LINE 4B - OTHER ADJUSTMENTS: BAD DEBTS 3,323,794. ROUNDING 2. EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 1500 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 335935 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICE BLOOD/BLOOD PATHOGENS 43100 NORTH AMERICA 0 0 MAINTENANCE N/A 8196 NORTH AMERICA 0 0 MEDICAL EQUIPMENT N/A 19235 NORTH AMERICA 0 0 SOFTWARE PROCUREMENT N/A 65100 NORTH AMERICA 0 0 STUDY N/A 240 NORTH AMERICA 0 0 SUPPLIES N/A 16120 0 0 0 0 0 0 489426 0 489426 0 0 0 0 0 0 SCCA SOURCES PERIPHERAL BLOOD STEM CELLS, BONE MARROW, AND CORD BLOOD FROM ALL OVER THE WORLD TO TREAT TRANSPLANT PATIENTS. IN DELIVERING STEM CELL TRANSPLANT SERVICES, SCCA SEEKS OUT THE MOST APPROPRIATE DONOR BASED ON CRITERIA OF HUMAN LEUKOCYTE ANTIGEN MATCH AND OTHER PERTINENT DONOR CRITERIA. HAVING THE CLOSEST POSSIBLE BONE MARROW DONOR MATCH IS CRUCIAL TO THE SURVIVAL OF THE PATIENT. ALSO, SOME OF THE FOREIGN DONOR ORGANIZATIONS HAVE HIGHER LEVELS OF TYPING ON THEIR DONOR WHICH REDUCED PATIENT COSTS. 1 1 1 X 1 X 1 1 1 0 1 1 3510709 3510709 0.01080 31460827 15994959 15465868 0.04760 1626326 806493 819833 0.00250 36597862 16801452 19796410 0.06090 2182036 2182036 0.00670 3753387 39630 3713757 0.01140 221688 221688 0.00070 4540243 417258 4122985 0.01270 931416 931416 0.00290 11628770 456888 11171882 0.03440 48226632 17258340 30968292 0.09530 1 3323794 48697635 53248889 -4551254 X 1 1 1 1 SEATTLE CANCER CARE ALLIANCE

1959 NE PACIFIC STREET SEATTLE WA 98195

X X ACUTE CARE HOSPITAL SEATTLE CANCER CARE ALLIANCE 1 0 1 1 200.000000000000 1 300.000000000000 1 X X X X X X X 1 1 X X 1 1 X X X X 0 X X X 0 0 3 SEATTLE CANCER CARE ALLIANCE HOUSE

207 PONTIUS AVE N SEATTLE WA 98109

TEMPORARY MEDICAL HOUSING FACILITY SCCA NW HSPTL RADIATION ONCOLOGY CLNC

1560 N 115TH ST - SUITE G-16B SEATTLE WA 981338498

HOSPITAL BASED OUTPATIENT CLINIC SEATTLE CANCER CARE ALLIANCE

825 EASTLAKE AVE E SEATTLE WA 98109

HOSPITAL BASED OUTPATIENT CLINIC PART I, LINE 3C: IN ACCORDANCE WITH WAC 246-453-040 AND SUBJECT TO SCCA FINANCIAL RESOURCES, PATIENTS WILL BE ELIGIBLE TO BE CONSIDERED FOR SOME FORM OF CHARITY CARE IF THEY SUBMIT THE NECESSARY APPLICATION AND IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME AT OR BELOW 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE. IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME AT OR BELOW 200% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE, THE PATIENT WILL BE ELIGIBLE FOR CHARITY CARE IN THE AMOUNT EQUAL TO THE UNPAID BALANCE REMAINING AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP HAVE BEEN EXHAUSTED. IF THE PARTY RESPONSIBLE FOR PAYMENT HAS A FAMILY INCOME BETWEEN 200% AND 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE, THE PATIENT WILL BE ELIGIBLE FOR CHARITY CARE BASED ON A SLIDING FEE SCALE FOR THE UNPAID BALANCE REMAINING AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP HAVE BEEN EXHAUSTED. RESPONSIBLE PARTIES WHOSE INCOME EXCEEDS 300% OF THE FEDERAL POVERTY STANDARD AS ADJUSTED FOR FAMILY SIZE BUT WHO HAVE INCURRED CATASTROPHIC ACCOUNT BALANCES AFTER ALL SOURCES OF THIRD PARTY COVERAGE AND SPONSORSHIP WILL BE CONSIDERED FOR CHARITY CARE ON A CASE-BY-CASE BASIS. PART I, LINE 6A: SCCA COMPLETED AN ANNUAL REPORT FOR FY12 AND IT INCLUDES THE COMMUNITY BENEFIT REPORT INFORMATION. IT IS MADE AVAILABLE TO THE PUBLIC AT THE FRONT DESK AND ON OUR WEBSITE. SCCA'S COMMUNITY BENEFIT INFORMATION IS NOT DISCLOSED IN A REPORT PREPARED BY A RELATED ORGANIZATION. PART I, LINE 7: SCCA USED A COST ACCOUNTING APPROACH TO CALCULATE ITS SUBSIDIZED HEALTH SERVICES FOR COMMUNITY BENEFIT REPORTING ON SCHEDULE H. SCCA CALCULATED ITS DIRECT PATIENT CARE FOR NUTRITION THERAPY SERVICES BASED ON THE NUMBER AND TYPE OF VISITS ENCOUNTERED USING A STANDARDIZED LENGTH OF VISIT PER VISIT TYPE AND THE AVERAGE REGISTERED DIETICIAN SALARY INCLUDING FRINGE BENEFITS. PART I, LINE 7G: THERE ARE NO PHYSICIAN CLINIC EXPENSES INCLUDED. SCCA IS REPORTING NUTRITIONAL THERAPY SERVICES AS A SUBSIDIZED HEALTH SERVICE AS A COMMUNITY BENEFIT.SCCA PROVIDES AMBULATORY ONCOLOGY MEDICAL NUTRITION THERAPY SERVICES FOR ALL PATIENTS. SCCA EMPLOYS HIGHLY TRAINED, ONCOLOGY-CERTIFIED DIETITIANS TO TREAT PATIENTS THROUGHOUT THE CANCER SPECTRUM OF PREVENTION, ACTIVE TREATMENT, SURVIVORSHIP, AND PALLIATIVE CARE. THE NUTRITION SERVICES PROVIDED AS OF JANUARY 2012 WERE NO LONGER COVERED BY INSURANCE OR MEDICARE. THE SERVICE PROVIDED WOULD NOT BE AVAILABLE IN THE GENERAL COMMUNITY. PATIENTS UNDERGOING TRANSPLANTATION AND CANCER TREATMENTS SUFFER HIGH NUTRITION ACUITY REQUIRING SPECIALIZED KNOWLEDGE FOR EVALUATION AND TREATMENT. PART I, L7 COL(F): BAD DEBT EXPENSE INCLUDED IN FORM 990, PART IX WAS $3,323,794. IT WAS SUBTRACTED UTILIZING WORKSHEET 1 FROM THE TOTAL ON FORM 990, PART IX TO ARRIVE AT THE DENOMINATOR USED TO CALCULATE THIS COLUMN. SCCA'S POSITION ON OVERALL COMMUNITY BENEFIT REPORTED ON PART I: THE TOTAL FINANCIAL ASSISTANCE AND COMMUNITY BENEFIT AT COST AMOUNTS REPORTED ON SCHEDULE H PART I LINE 7, UNDERSTATE THE TRUE FINANCIAL ASSISTANCE AND COMMUNITY BENEFIT PROVIDED BY SCCA VIA BAD DEBT EXPENSE AND THE FACT THAT MEDICARE PROGRAM DOES NOT COVER SCCA'S COSTS. IF BAD DEBT EXPENSE AND THE MEDICARE PROGRAM WERE INCLUDED IN THE COMPUTATION OF THE LINE 7 - FINANCIAL ASSISTANCE AND CERTAIN OTHER COMMUNITY BENEFITS AT COST, THE PERCENTAGE REPORTED ON LINE 7K OF 9.53% WOULD INCREASE TO 17.24%. PART III, LINE 4: PART III SECTION A LINE 2: THE EXPENSE REPORTED ON PART III SECTION A LINE 2 IS BAD DEBT EXPENSE AS REPORTED IN SCCA'S GAAP FINANCIAL STATEMENTS.PART III SECTION A LINE 3: THIS LINE IS BLANK FOR THE SCCA. PART III SECTION A LINE 4: DISCOUNTS ON ACCOUNTS PRIOR TO BAD DEBT STATUS: FOR A PATIENT WHO HAS INSURANCE, CONTRACTUAL ADJUSTMENTS ARE APPLIED TO THE ACCOUNT BASED ON THE INSURANCE COMPANY CONTRACT IN FORCE. THE REMAINING SELF PAY AMOUNTS ARE NOT FURTHER ADJUSTED. FOR A PATIENT WITH NO INSURANCE, A 10% DISCOUNT IS APPLIED AT TIME OF SERVICE. NO OTHER SPECIFIC DISCOUNTS ARE MADE TO PATIENT ACCOUNTS. AMOUNTS WRITTEN OFF TO BAD DEBT EXPENSE REPRESENT THE UNPAID BALANCE AFTER INSURANCE CONTRACTUAL ADJUSTMENT, OR SELF PAY DISCOUNT, AND ANY PAYMENTS RECEIVED. ONCE AN ACCOUNT IS IN BAD DEBT STATUS, ANY PAYMENTS RECEIVED ON A PATIENT ACCOUNT CONTINUE TO REDUCE THE OUTSTANDING PATIENT ACCOUNT LIABILITY.ESTIMATED AMOUNT FOR PATIENTS WHO 'WOULD QUALIFY' FOR FINANCIAL ASSISTANCE:THE SCCA IDENTIFIES PATIENTS ELIGIBLE FOR FINANCIAL ASSISTANCE AND THE ACCOUNT IS DESIGNATED AS FINANCIAL ASSISTANCE WITHIN THE PATIENT ACCOUNTING SYSTEM. ALL OTHER ACCOUNTS ARE EVALUATED OVER A PERIOD OF TIME THROUGH A SERIES OF CRITERIA BEFORE DESIGNATION AS BAD DEBT. BECAUSE SCCA IS A SPECIALTY HOSPITAL TREATING CANCER PATIENTS, SCCA MAKES EVERY EFFORT TO COMMUNICATE WITH OUR PATIENTS THE PROGRAMS AND FINANCIAL ASSISTANCE POLICIES AVAILABLE TO ITS PATIENT POPULATION BEFORE, DURING, AND AFTER TREATMENT IS RECEIVED.COMMUNITY BENEFIT:SCCA BELIEVES THAT BAD DEBT EXPENSE SHOULD BE INCLUDED IN THE CALCULATION OF THE COMMUNITY BENEFIT. SCCA PROVIDED TREATMENT TO THOSE PATIENTS UNABLE TO PAY THEIR BILLS. IF SCCA DID NOT TREAT THESE PATIENTS, THEY WOULD BE TREATED BY SOMEONE ELSE IN THE COMMUNITY OR THROUGH A GOVERNMENTAL UNIT. BAD DEBT FOOT NOTE FROM THE CONSOLIDATED FINANCIAL STATEMENTS:FOR PATIENTS WHO DO NOT QUALIFY FOR CHARITY CARE, SCCA RECOGNIZES REVENUE ON THE BASIS OF ITS STANDARD RATES FOR SERVICES PROVIDED (OR ON THE BASIS OF DISCOUNTED RATES, IF NEGOTIATED OR PROVIDED BY POLICY). ON THE BASIS OF HISTORICAL EXPERIENCE, A SIGNIFICANT PORTION OF SCCA'S PATIENTS WILL BE UNABLE OR UNWILLING TO PAY FOR THE SERVICES PROVIDED. THUS, SCCA RECORDS A SIGNIFICANT PROVISION FOR BAD DEBTS RELATED TO PATIENTS IN THE PERIOD THE SERVICES ARE PROVIDED. PART III, LINE 8: SCCA COMPLETED LINE 6 USING THE ALLOWABLE COSTS FROM THE AS-FILED MEDICARE COST REPORT FOR FY12. THE METHODOLOGY USED TO COMPLETE THE MEDICARE COST REPORT WAS BASED ON THE CMS PROVIDER REIMBURSEMENT MANUAL PUB 15.SCCA CONSIDERS THE SHORTFALL ON MEDICARE SERVICES TO BE 100% COMMUNITY BENEFIT. HAD SCCA NOT DELIVERED THE SERVICES, THE SERVICES AND FINANCIAL LOSS WOULD FALL TO ANOTHER COMMUNITY HOSPITAL. PART III, LINE 9B: PATIENTS WHO HAVE BEEN APPROVED FOR 100% CHARITY ARE REMOVED FROM THE COLLECTIONS WORKFLOW SO THEIR ACCOUNTS WILL NOT BE SENT TO COLLECTIONS. PATIENTS WHO HAVE BEEN AWARDED TO PARTIAL CHARITY (40% OR 60%) MAY BE SENT TO COLLECTIONS IF THE REMAINING PATIENT BALANCES ARE NOT PAID OR ARRANGEMENTS MADE WITHIN 91 DAYS OF THE FIRST BILLING CYCLE. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 18D: SCCA DOES NOT OPERATE AN EMERGENCY ROOM FACILITY. SCCA HAS PROCEDURES IN PLACE WHEN A PATIENT ENTERS INTO AN EMERGENT CONDITION TO STABILIZE THE PATIENT AND MOVE THEM TO AN APPROPRIATE EMERGENCY FACILITY. SCCA STABILIZES THE PATIENT WITHOUT DISCRIMINATION AND ELIGIBILITY TO PAY. SEATTLE CANCER CARE ALLIANCE PART V, SECTION B, LINE 19D: TO DETERMINE THE MAXIMUM AMOUNT THAT CAN BE CHARGED TO FAP-ELIGIBLE INDIVIDUALS, SCCA USES THE REMAINING FAP PERCENTAGE MULTIPLIED BY THE GROSS CHARGES. IF THE PATIENT IS DEEMED FAP ELIGIBLE FOR 60%, THE AMOUNT BILLED TO THE ELIGIBLE PATIENT IS 40% MULTIPLIED BY THIER GROSS BILLED CHARGES. PART VI, LINE 2: SCCA IS A SPECIALTY HOSPITAL AND OUTPATIENT CLINIC DEDICATED TO PROVIDING STATE-OF-THE-ART PATIENT AND FAMILY CENTERED CARE, SUPPORTING THE CONDUCT OF CANCER CLINICAL RESEARCH AND EDUCATION, ENHANCING ACCESS TO IMPROVED CANCER INTERVENTIONS, AND ADVANCING THE STANDARD OF CANCER CARE, REGIONALLY AND BEYOND. IT BRINGS TOGETHER PHYSICIANS FROM THE FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE CHILDREN'S, AND THE UNIVERSITY OF WASHINGTON FOCUSED ON FORMULATING AND DELIVERING THE BEST CANCER TREATMENTS AVAILABLE. OUR NEEDS ASSESSMENT STRATEGY IS TO ANALYZE WHERE AND WHAT TYPE OF CANCER IS OCCURRING, DETERMINE WHERE COMPELLING SCIENCE EXISTS, AND MAKE INVESTMENTS TO GROW THESE PROGRAMS.SCCA, IN CONJUNCTION WITH FRED HUTCHINSON CANCER RESEARCH CENTER, UNIVERSITY OF WASHINGTON, AND SEATTLE CHILDREN'S, REVIEWS THE OCCURRENCE RATES IN THE TYPES OF CANCERS IN COMPARISON TO WHERE RESEARCH DOES NOT EXIST AND MAKES STRATEGIC INVESTMENTS TO DEVELOP SCIENCE AND BREAKTHROUGHS IN AREAS OF CANCER NOT BEING PURSUED BY OTHERS.WITH THE COMBINED EFFORTS OF ALL THREE INSTITUTIONS, STATE-OF-THE-ART RESEARCH IS CONDUCTED, DELIVERED TO OUR PATIENT POPULATION, AND SHARED WITH THE COMMUNITY.SCCA HAS A FORMAL COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) PROCESS UNDERWAY THAT IS IN COMPLIANCE WITH THE PATIENT PROTECTION ACT AND IRS CODE SECTION 501(R). SCCA IS FOCUSED ON THE STATE OF WASHINGTON AND THE IMPACT OF CANCER, IDENTIFYING THE LEADING CAUSES OF DEATH FROM CANCER. SCCA DEFINED ITS CHNA COMMUNITY TO BE THE THREE SURROUNDING COUNTIES: KING, PIERCE, AND SNOHOMISH COUNTIES. A STUDY OF THE DEMOGRAPHICS OF THE THREE COUNTIES BY GENDER AND ETHNICITY AS COMPARED TO THE SCCA PATIENT POPULATION WAS ANALYZED. THE LEADING CAUSES OF DEATH IN THE THREE-COUNTY AREA VERSUS WASHINGTON STATE WERE REVIEWED. THE ANALYSIS IDENTIFIED CANCER AS THE LEADING CAUSE OF DEATH. FURTHER INVESTIGATION WAS COMPLETED LOOKING AT THE TYPES OF CANCER CAUSING MORTALITY. THE NUMBER ONE CAUSE OF DEATH IN WASHINGTON STATE AND THE THREE SURROUNDING COUNTIES WAS IDENTIFIED TO BE LUNG CANCER, FOLLOWED BY PROSTATE, BREAST, COLORECTAL, AND PANCREAS CANCERS. AS PART OF THE CHNA PROCESS, SCCA LOOKED AT PREVENTION AND SCREENING AND THE CHRONIC DISEASE RISK FACTORS. SCCA REVIEWED ITS PROGRAMS ADDRESSING COMMUNITY NEED AND IDENTIFIED AREAS TO FOCUS ON TO HELP CLOSE THE GAP. SCCA IS IN PROCESS TO REVIEW WITH ITS BOARD OF DIRECTORS THE IMPLEMENTATION STRATEGY RESULTING FROM THE CHNA. SCCA SHOULD BE COMPLIANT BY JUNE 30, 2013 WITH THE PATIENT PROTECTION ACT AND THE CODE SECTION 501(R) PROVISIONS. PART VI, LINE 3: EACH PATIENT ENTERING INTO THE SCCA CLINIC IS GIVEN A BROCHURE DESCRIBING THE FINANCIAL PROGRAMS AVAILABLE WITH THE CONTACT INFORMATION. A FINANCIAL COORDINATOR IS AVAILABLE FREE OF CHARGE TO HELP PATIENTS SIFT THROUGH THE INFORMATION AND HELP COMPLETE THE NECESSARY PAPERWORK TO APPLY FOR ASSISTANCE. INTERPRETER SERVICES ARE AVAILABLE IF NEEDED TO HELP. PART VI, LINE 4: SCCA IS LOCATED IN SEATTLE, WA. THE PATIENT POPULATION UTILIZING THE SERVICES OF THE SCCA ARE PRIMARILY LOCATED IN THE PACIFIC NORTHWEST; HOWEVER, SCCA HAS PATIENTS FROM ALL OVER WORLD. THE REGIONAL POPULATION ESTIMATE FOR THE STATES COMPRISING THE PACIFIC NORTHWEST (WA,OR, ID, MT, AK) ACCORDING TO THE US CENSUS BUREAU FOR 2010 IS 13,822,842.THE SCCA NETWORK PROGRAM INCLUDES 11 COMMUNITY CANCER CENTER AFFILIATES IN WASHINGTON, ALASKA, AND MONTANA WITH FUTURE RELATIONSHIPS BEING DEVELOPED IN WYOMING AND IDAHO. THE AFFILIATIONS ARE WITH COMMUNITY CANCER CENTERS AND PROVIDE ACCESS TO RESOURCES AND THERAPIES FOR ALL THEIR PATIENTS, WHICH INCLUDE THE MEDICALLY UNDERSERVED AREA (MUA) POPULATIONS. THE MUA PATIENT POPULATION RECEIVES THE BENEFIT OF SCCA'S EXPERTISE WITHOUT HAVING TO LEAVE HOME. THE LOCAL AREA SCCA RESIDES IN CONSISTS OF KING, SNOHOMISH, AND PIERCE COUNTIES. THE METROPOLITAN AREA POPULATION ESTIMATE ACCORDING TO THE US CENSUS BUREAU FOR 2010 IS 3,439,809. KING, SNOHOMISH, AND PIERCE COUNTIES ALL HAVE FEDERALLY-DESIGNATED MEDICALLY UNDERSERVED COMMUNITIES. KING COUNTY HAS SEVEN FEDERALLY QUALIFIED HEALTH CENTERS, SNOHOMISH COUNTY HAS ONE, AND PIERCE COUNTY HAS TWO. PIERCE COUNTY IS CONSIDERED A MEDICALLY UNDERSERVED COUNTY BY THE WASHINGTON STATE DEPARTMENT OF PUBLIC HEALTH.SCCA IS COMMITTED TO PROVIDING STATE-OF-THE-ART, PATIENT AND FAMILY CENTERED CARE, SUPPORTING THE CONDUCT OF CANCER CLINICAL RESEARCH AND EDUCATION, ENHANCING ACCESS TO IMPROVED CANCER INTERVENTIONS, AND ADVANCING THE STANDARD OF CANCER CARE REGIONALLY AND BEYOND. SCCA HAS DIRECT RELATIONSHIPS WITH A COUPLE OF FEDERALLY QUALIFIED HEALTH CENTERS THAT ARE LOCATED IN A DESIGNATED MUA IN KING COUNTY, WASHINGTON. PUBLIC HEALTH SEATTLE KING COUNTY (PHSKC) AND SEAMAR HAVE SPECIFIC CONTRACTS WITH SCCA AS PART OF OUR OUTREACH SERVICES TO PROVIDE PREVENTIVE HEALTH SCREENINGS AND ALSO SERVE ITS DESIRE TO REACH THE LOCAL UNDERSERVED COMMUNITIES. THE SCCA'S RELATIONSHIP WITH PHSKC IS PART OF THE WASHINGTON BREAST AND CERVICAL HEALTH PROGRAM (WBCHP). THE PURPOSE OF WBCHP IS TO REDUCE MORTALITY AND MORBIDITY FROM BREAST AND CERVICAL CANCER BY EARLY DETECTION OF CANCER THROUGH REGULAR MAMMOGRAM AND PAP TEST SCREENINGS, DIAGNOSTIC SERVICES, AND PROMPT ACCESS TO CANCER TREATMENT. SCCA ACCEPTS REFERRALS FROM PHSKC WHEN THE PRIMARY CARE PHYSICIAN HAS DETECTED SOMETHING OF INTEREST. SCCA PERFORMS DIAGNOSTICS, AND IF THE PATIENTS ARE DEEMED TO HAVE CANCER, WILL TREAT THESE PATIENTS. SCCA ALSO HAS THE UNIQUE ABILITY TO HELP ENROLL PATIENTS INTO THE WBCHP PROGRAM. ONCE IDENTIFIED BY SCCA, THEY ARE FAST TRACKED AT THE WASHINGTON STATE DEPARTMENT OF SOCIAL AND HEALTH SERVICES INTO WBCHP. PATIENTS WHO COME TO SCCA DIRECTLY TO HAVE DIAGNOSTIC SERVICES COMPLETED AND CANCER IS FOUND CAN BE ENROLLED DIRECTLY BY THE SCCA INTO THE WBCHP. ENROLLMENT INTO WBCHP IS DEPENDENT ON ELIGIBILITY CRITERIA. WBCHP IS FUNDED BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION, WASHINGTON STATE, PUGET SOUND AFFILIATE SUSAN G. KOMAN BREAST CANCER FOUNDATION, AND THE BREAST CANCER PREVENTION FUND.THE SCCA'S RELATIONSHIP WITH SEAMAR IS TO PROVIDE CLINICAL EDUCATION OPPORTUNITIES FOR PRIMARY CARE PROVIDERS IN THE AREAS OF EARLY DETECTION AND PREVENTION OF CANCER. ANOTHER ASPECT OF THE SEAMAR RELATIONSHIP IS TO FOSTER CONTINUITY OF CARE FOR SEAMAR PATIENTS WHO ARE DIAGNOSED WITH CANCER BETWEEN SEAMAR, SCCA, AND SCCA'S NETWORK MEMBERS. SEA MAR COMMUNITY HEALTH CENTER IS A COMMUNITY-BASED ORGANIZATION COMMITTED TO PROVIDING QUALITY, COMPREHENSIVE HEALTH, HUMAN, AND HOUSING SERVICES TO DIVERSE COMMUNITIES, SPECIALIZING IN SERVICE TO LATINOS. SEAMAR'S CLINICS ARE LOCATED IN ELEVEN COUNTIES IN WASHINGTON STATE. PART VI, LINE 5: SCCA BRINGS TOGETHER THE RESEARCH AND TREATMENT EXPERTISE OF DOCTORS AND SCIENTISTS FROM THREE WORLD-CLASS INSTITUTIONS DEDICATED TO TURNING CANCER PATIENTS INTO CANCER SURVIVORS. AS THE PACE OF MEDICAL BREAKTHROUGHS ACCELERATES, SO DOES OUR ABILITY TO TARGET THERAPIES TO INDIVIDUAL PATIENTS' BIOLOGY AND THE GENETIC SIGNATURE OF THEIR DISEASE THANKS TO ADVANCEMENTS IN GENOMICS AND GENOMIC SCREENING. RECENTLY OUR KNOWLEDGE IN CANCER NOW EXTENDS TO THE ABILITY TO DIFFERENTIATE BETWEEN INDIVIDUAL TUMORS OF THE SAME TYPE. CREDIT GOES TO OUR PARTNERS AT UW MEDICINE AND FRED HUTCHINSON CANCER RESEARCH CENTER FOR THIS BREAKTHROUGH DIAGNOSTIC CALLED UW-ONCOPLEX. UW-ONCOPLEX IDENTIFIES GENETIC VARIANTS, WHICH ALLOWS US TO TARGET THE INDIVIDUAL'S SPECIFIC DISEASE-TYPE WITH THE TREATMENT REGIMEN THAT WILL BE MOST EFFECTIVE. WHEN IT COMES TO TREATMENTS, TWO NEW OPTIONS CALLED ADOPTIVE IMMUNOTHERAPY AND PROTON RADIATION ARE HIGHLY TARGETED APPROACHES. IN IMMUNOTHERAPY, OUR SCIENTISTS ARE NOW ABLE TO TAKE OUT THE T-CELLS - SPECIFICALLY CENTRAL MEMORY T-CELLS THAT ARE THE MOST RESPONSIBLE FOR IMMUNE FUNCTION - AND GENETICALLY RE-ENGINEER THEM, PUTTING IN A RECEPTOR THAT BINDS A SPECIFIC TYPE OF TUMOR. SIMILARLY, RADIATION FROM PROTON BEAMS IS FAR MORE TARGETED THAN CONVENTIONAL X-RAYS. THERE IS AN OBVIOUS BENEFIT FOR CHILDREN AND YOUNG ADULTS: REDUCING THEIR TOTAL RADIATION EXPOSURE LOWERS THE RISK OF SECONDARY CANCERS LATER IN LIFE. SCCA TOGETHER WITH OUR PARTNERS WILL BE RESEARCHING THE BENEFITS FOR BOTH CHILDREN AND ADULTS WITH A VARIETY OF CANCERS IN OUR NEW FACILITY, SCCA PROTON THERAPY, A PROCURE CENTER, WHICH OPENED ITS DOORS IN MARCH 2013. SCCA HAS COINED THE TERM 'PRECISION MEDICINE' TO DESCRIBE THIS SET OF INNOVATIONS. AS CANCER DOCTORS, WE WANT TO INCREASE THE DEGREE OF PRECISION AT EVERY POINT OF CONTACT WITH OUR PATIENTS: IDENTIFYING GENETIC RISK FACTORS HELPS US GET BETTER AT PREVENTING CANCER. UNDERSTANDING THE BIOLOGY OF EACH PATIENT'S SPECIFIC DISEASE IS A POWERFUL DIAGNOSTIC TOOL. PRECISELY TARGETING MOLECULES MAKES US BOTH MORE LETHAL IN DESTROYING TUMORS AND LESS APT TO CAUSE UNWANTED SIDE EFFECTS AND RECURRENCES.PRECISION MEDICINE ALSO HAS THE POTENTIAL TO REDUCE THE COST OF CANCER CARE ACROSS THE ENTIRE POPULATION, CHIEFLY THROUGH THE INTRODUCTION OF STANDARDIZED TREATMENT PROTOCOLS FOR EACH DISEASE. WE CALL THESE 'CLINICAL PATHWAYS'. THE TRADITIONAL MODEL ALLOWS FOR CONSIDERABLE VARIATION IN TREATMENT, BASED ON EACH PHYSICIAN'S INDIVIDUAL EXPERIENCE. (INCIDENTALLY, THIS INDIVIDUAL ELEMENT IS ONE OF THE REASONS WE AVOID THE CURRENTLY POPULAR TERM 'PERSONALIZED MEDICINE'). IN CONTRAST, THE DISCIPLINE OF PRECISION MEDICINE IS BASED ON EVIDENCE GATHERED FROM MANY DOCTORS IN DIFFERENT CLINICS. FOR EACH SEPARATE TUMOR TYPE AND STAGE, WE'RE WORKING TO IDENTIFY THE BEST THERAPY THAT IS ASSOCIATED WITH THE LEAST TOXICITY - AND, TO THE EXTENT POSSIBLE, AT THE LOWEST COST. WE ARE HARD WIRING THESE CLINICAL PATHWAYS INTO OUR SYSTEM TO PROVIDE PATIENTS WITH THE MOST EFFECTIVE TREATMENTS, WHILE ELIMINATING WASTE, DECREASING THE CHANCE FOR ERROR, REDUCING COSTS, AND INCREASING OVERALL EFFICIENCY. SCCA PRUDENTLY MANAGES IT RESOURCES AND USE OF SURPLUS FUNDS. THIS STRONG OVERSIGHT OF OUR RESOURCES ENABLES SCCA TO CONTINUE ITS COMMITMENT TO PERFORM THE RESEARCH, TESTING, AND EXPLORATION OF WAYS TO IMPROVE PATIENTS' LIVES AS PART OF THE FIGHT AGAINST CANCER. PART VI, LINE 6: SCCA IS NOT PART OF AN AFFILIATED HEALTH CARE SYSTEM. 1 UNIVERSITY OF WASHINGTON FOUNDATION PO BOX 358045 SEATTLE WA 98195 943079432 501(C)(3) 145622 TO SUPPORT UNIVERSITY OF WASHINGTON FOUNDATION EVENTS FRED HUTCHINSON CANCER RESEARCH CENTER 1100 FAIRVIEW AVE N SEATTLE WA 98109 237156071 501(C)(3) 66759 TO FUND RESEARCH SPECIFIC TO CANCER RESEARCH ACTIVITIES OLYMPIC MEDICAL CENTER FOUNDATION 939 CAROLINE PORT ANGELES WA 98362 911285758 501(C)(3) 9600 TO SUPPORT OLYMPIC MEDICAL CENTER EVERGREEN HEALTHCARE FOUNDATION 12040 NE 128TH STREET KIRKLAND WA 98034 911519430 501(C)(3) 8000 TO SUPPORT EVERGREEN HEALTHCARE FOUNDATION PROGRAMS AND INITIATIVES 4 0 CASH FOR EMERGENCIES (ONE TIME ASSISTANCE PROGRAM) 391 36503 FUNERAL 2 572 TRANSPORTATION 77 4473 FOOD 754 43212 3493 FMV GIFT CARDS PROVIDED TO PATIENTS FOR FOOD AND GROCERY STORES SHELTER 311 132063 100878 COST RENTS PAID FOR PATIENTS MEDICAL 9 6519 PARKING 66 7932 SUNDRIES 807 14191 FMV BOOKS, CANDY, MAGAZINES, MOVIES, BLANKETS, GAMES, & OTHERS. UTILITIES 16 3791 WIGS 373 1201 6846 FMV HATS & WIGS FOR CANCER PATIENTS FURNITURE 3 3980 FMV DIRECT PAYMENT FOR FURNITURE NEEDED FOR SPECIFIC PATIENTS PROSTHESIS 5 180 FMV PARTS & SUPPLIES FOR PROSTHETICS TICKETS 4313 266190 FMV EVENT TICKETS TO SPORTS GAMES, ART PERFORMANCES, AND LOCAL ATTRACTIONS TUITION ASSISTANCE 1 10000 PEGGY MEANS SCHOLARSHIP 2 16450 STEINBERG SCHOLARSHIP 2 3000 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: WITH REGARD TO GRANTS TO ORGANIZATIONS REPORTED ON SCHEDULE I, PART II, THE SCCA VERIFIES THE GRANTEES ARE QUALIFIED 501(C)(3) ORGANIZATIONS WITH A MISSION COMPATIBLE WITH THAT OF SCCA. THE SCCA RELIES ON THE GRANTEE ORGANIZATION MAINTAINING ITS TAX EXEMPT STATUS WITH THE IRS AND DOES NOT IMPOSE THE BURDEN OF REPORTING BACK TO SCCA AS TO THE EXPENDITURE OF GRANT FUNDS. WITH REGARD TO GRANTS OR OTHER ASSISTANCE TO INDIVIDUALS REPORTED ON SCHEDULE I, PART III, MOST OF THE REQUESTS FOR ASSISTANCE ARE MADE THROUGH PATIENT FAMILY SERVICES. THESE REQUESTS ARE CONSIDERED IN ACCORDANCE WITH A MODIFICATION TO SCCA'S CHARITY CARE POLICY AND ASSISTANCE IS PROVIDED IN RESPONSE TO SPECIFIC NEEDS OF INDIVIDUALS FOR THE INTENDED PURPOSE BY PAYING FOR CERTAIN ASSISTANCE DIRECTLY ON BEHALF OF THE INDIVIDUAL. ALSO, PATIENT FAMILY SERVICES MAINTAINS CONTACT WITH PATIENTS RECEIVING ASSISTANCE THROUGHOUT THEIR TREATMENT AT SCCA. WITH REGARD TO SCHOLARSHIPS GIVEN, AN APPLICATION IS MADE AND REVIEWED BY THE SENIOR MANAGEMENT STAFF. VERY SPECIFIC CRITERIA ARE REQUIRED. ONLY BONA FIDE TUITION AND FEES QUALIFY FOR FUNDING. X 1 1 X X X X 0 0 0 0 0 0 0 0 0 FRED APPELBAUM MD 312533 0 0 0 0 0 0 0 0 0 312533 0 0 0 NORMAN HUBBARD 434080 0 62935 0 0 0 31410 0 15642 0 544067 0 0 0 MADELINE BUELT 321510 0 29501 0 0 0 31410 0 21395 0 403816 0 0 0 F MARC STEWART MD 274720 0 0 0 0 0 0 0 0 0 274720 0 0 0 JONATHAN TINGSTAD 348068 0 46464 0 0 0 31410 0 21404 0 447346 0 0 0 DEBORAH GENTZEN 235613 0 22500 0 0 0 24060 0 20420 0 302593 0 0 0 DAVID ACKERSON 211621 0 20500 0 0 0 23073 0 10217 0 265411 0 0 0 CHERYL WYMAN 188564 0 19500 0 0 0 20488 0 14180 0 242732 0 0 0 GRETCHEN HANNA 187634 0 19000 0 0 0 13794 0 12688 0 233116 0 0 0 JOSEPH NORTON 185682 0 17561 0 0 0 20255 0 20139 0 243637 0 0 0 ZAKARIA RAMADAN-JRADI 179060 0 18584 0 0 0 19273 0 19834 0 236751 0 0 0 ALEANA WAITE 169315 0 17500 0 0 0 17395 0 15788 0 219998 0 0 0 DEBORAH STENHJEM 158305 0 16200 0 0 0 16117 0 15586 0 206208 0 0 0 KRISTINE LOGAN 149835 0 15000 0 0 0 14524 0 9521 0 188880 0 0 0 SUSAN HAMMOND 148603 0 15000 0 0 0 2475 0 13603 0 179681 0 0 0 MOREEN DUDLEY 139556 0 14500 0 0 0 13865 0 13580 0 181501 0 0 0 ALPHONSO EMERY 140042 0 14000 0 0 0 13203 0 8259 0 175504 0 0 0 MARGARET OWENS 160214 0 0 0 0 0 13772 0 4276 0 178262 0 0 0 LINDA LAKE 142472 0 5000 0 0 0 5466 0 9424 0 162362 0 0 0 BARBARA JAGELS 131383 0 13991 0 0 0 13191 0 19444 0 178009 0 0 0 MICHELLE HALL 130200 0 13368 0 0 0 12365 0 15270 0 171203 0 0 0 SHARI MCCLURE 128768 0 12875 0 0 0 11713 0 8035 0 161391 0 0 0 PART I, LINE 1A SCCA LEADERSHIP TEAM HAS MEMBERSHIPS AT LOCAL CLUBS TO ENABLE MEETINGS AND RECRUITMENT TO TAKE PLACE. NORMAN HUBBARD, MARC STEWART, AND JONATHAN TINGSTAND RECEIVE THESE BENEFITS. SCCA HAS A DETAILED EXPENSE REIMBURSEMENT POLICY FOR TRAVEL AND ENTERTAINMENT. THE HEALTH/SOCIAL CLUB DUES ARE NOT SPECIFICALLY INCLUDED IN THE WRITTEN POLICY. SCCA REIMBURSES FOR THESE EXPENSES SUBJECT TO THE TERMS OF THE OVERALL POLICY. ANY PAYMENTS WHICH ARE A TAXABLE FRINGE BENEFIT ARE INCLUDED IN THE TAXABLE INCOME REPORTABLE ON FORM W-2 FOR THE RECIPIENT. ALL RELATED CORPORATE EXPENSES ARE MONITORED BY THE AP SUPERVISOR FOR PERSONAL/BUSINESS USE FOR COMPLIANCE WITH THE ACCOUNTABLE PLAN AND REIMBURSEMENT POLICY. SUPPLEMENTAL INFORMATION PART III FRED APPELBAUM, MD RECEIVED COMPENSATION OF $312,533 FROM FRED HUTCHINSON CANCER RESEARCH CENTER, AN UNRELATED ORGANIZATION FOR SERVICES PROVIDED TO SEATTLE CANCER CARE ALLIANCE. F. MARC STEWART, MD RECEIVED COMPENSATION OF $274,720 FROM FRED HUTCHINSON CANCER RESEARCH CENTER, AN UNRELATED ORGANIZATION FOR SERVICES PROVIDED TO SEATTLE CANCER CARE ALLIANCE. WASHINGTON HEALTH CARE FACILITIES AUTHORITY 911108929 93978E2C5 2009-02-03 87819178 CAPITAL ACQUISITION, REFINANCE OLD DEBT ISSUED 3/6/2001 0 0 0 WASHINGTON HEALTH CARE FACILITIES AUTHORITY 911108929 2010-11-18 21415000 TO REFUND 2008 WEEKLY RATE BONDS 0 0 0 3795000 87819178 7391894 43483521 1671200 35272376 2010 1 0 1 1 761000 21415000 21090000 325000 2009 1 0 1 1 0 0 0 1 1 0.00550 0.00000 0.00550 1 0 0 0 0 0.00000 0.00000 0.00000 1 0 0 0 0 0 0 0 1 0 0 0 0 X PART III, LINE 4, COLUMN A THE PERCENTAGE REPORTED ON LINE 4 REPRESENTS THE PERCENTAGE OF RESEARCH REVENUE FROM BOTH GOVERNMENTAL AND INDUSTRY SPONSORED RESEARCH. GOVERNMENT SPONSORED RESEARCH FALLS INTO A PRIVATE BUSINESS USE SAFE HARBOR, INDUSTRY SPONSORED DOES NOT. BECAUSE THE COMBINED REVENUE FROM THE GOVERNMENT AND PRIVATELY SPONSORED RESEARCH IS LESS THAN THE APPLICABLE THRESHOLD, SCCA HAS ELECTED NOT TO DEVOTE THE RESOURCES REQUIRED TO ALLOCATE THE AGGREGATE RESEARCH REVENUE BETWEEN GOVERNMENT AND PRIVATELY SPONSORED RESEARCH. AS SUCH, PRIVATE BUSINESS USE DUE TO RESEARCH IS OVERSTATED. SCCA DOES NOT HAVE DIRECT CONTRACTS WITH INDUSTRY SPONSORED CORPORATIONS. SCCA PERFORMS SERVICES PRIMARILY FOR UNIVERSITY OF WASHINGTON, A GOVERNMENTAL ENTITY, AND FRED HUTCHINSON CANCER RESEARCH CENTER, A 501(C)(3) ENTITY. UNIVERSITY OF WASHINGTON AND FRED HUTCHINSON CANCER RESEARCH CENTER ARE CONDUCTING THE RESEARCH AND HAVE THE DIRECT CONTRACTS WITH THE GOVERNMENT AND PRIVATE INDUSTRY SPONSORED RESEARCH. X 8738 COST/SELLING PRICE X 234 3493 COST/SELLING PRICE X 5 180 COST/SELLING PRICE X EVENT TICKETS 4313 266190 COST/SELLING PRICE X HATS/WIGS 368 6845 COST/SELLING PRICE X FURNITURE 3 3980 COST/SELLING PRICE 0 0 1 0 METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS: PART I, COLUMN (B): THE NUMBER OF ITEMS RECEIVED WAS USED TO DETERMINE THE AMOUNTS IN COLUMN B. FORM 990, PART I, LINE 6 THE VOLUNTEERS OFFER DIRECT SUPPORT IN SOCIAL, EMOTIONAL, AND PRACTICAL WAYS TO CONNECT WITH PATIENTS AND FAMILIES THROUGHOUT EACH PHASE OF A PATIENT'S EXPERIENCE WITH SCCA. THE SCCA HAS 19 VOLUNTEER ROLES: BREAST CENTER, CHILD LIFE, DRIVERS, EVENTS COMMITTEE, HUTCH SCHOOL, RAIN OR SHINE, GUEST SERVICES, WIG FITTER, SCCA HOUSE KITCHEN HOST, PATIENT EDUCATION, SHINE, COSMETOLOGY/BARBER, WOMEN'S CENTER LOBBY, PATIENT/FAMILY SERVICES, PHYSICAL THERAPY, COMFORT MASSAGE, HEALING MUSIC, GENERAL ONCOLOGY LOBBY. THE 19 MEMBERS OF THE BOARD ALSO SERVE AS VOLUNTEERS. FORM 990, PART VI, SECTION A, LINE 2 MARK GROUDINE, RICH MCCUNE, MYRA TANITA, FRED APPLEBAUM, AND F. MARC STEWART HAVE BUSINESS RELATIONSHIPS. EACH NAMED INDIVIDUAL SERVES AS A SCCA BOARD MEMBER, AND THESE INDIVIDUALS ARE ALSO BOARD MEMBERS, OFFICERS, DIRECTORS, OR KEY EMPLOYEES OF ANOTHER ORGANIZATION. ROBB BAKEMEIER, LISA BRANDENBURG, PAT HAGAN, AND BRUDER STAPLETON HAVE BUSINESS RELATIONSHIPS. EACH NAMED INDIVIDUAL SERVES AS A SCCA BOARD MEMBER, AND THESE INDIVIDUALS ARE ALSO BOARD MEMBERS, OFFICERS, DIRECTORS OR KEY EMPLOYEES OF ANOTHER ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 SCCA HAS THREE MEMBERS. MEMBERS MUST BE GOVERNMENTAL ENTITIES OR ORGANIZATIONS EXEMPT UNDER IRC SECTION 501(C)(3). EACH MEMBER CURRENTLY HAS A 33 1/3% VOTING INTEREST. NO NEW MEMBER MAY BE ADMITTED TO THE CORPORATION WITHOUT THE APPROVAL OF EXISTING MEMBERS HOLDING AGGREGATE VOTING INTERESTS OF AT LEAST 75%. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER WILL APPOINT SIX MEMBERS OF THE EIGHTEEN DIRECTORS OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 7B THE BOARD OF DIRECTORS OF THE CORPORATION MAY NOT, EXCEPT BY AFFIRMATIVE VOTE OF 75% OF THE DIRECTORS IN OFFICE AND WITH THE APPROVAL OF THE MEMBERS HOLDING AGGREGATE VOTING INTERESTS OF AT LEAST 75%, (A) AMEND, ALTER OR REPEAL CERTAIN SECTIONS OF THE CORPORATION'S BYLAWS; (B) REMOVE ANY DIRECTOR OR THE CHAIR OF THE CORPORATION; PROVIDED THAT A MEMBER MAY REMOVE A DIRECTOR APPOINTED BY SUCH MEMBER AT ANY TIME; (C) AMEND THE ARTICLES OF INCORPORATION OF THE CORPORATION; (D) ADOPT A PLAN OF MERGER OR CONSOLIDATION WITH ANOTHER CORPORATION; (E) AUTHORIZE THE SALE, LEASE, OR EXCHANGE (OR PLEDGING AS SECURITY) OF ALL OR SUBSTANTIALLY ALL OF THE PROPERTY AND ASSETS OF THE CORPORATION OR ANY ASSET NOT IN THE ORDINARY COURSE OF BUSINESS; (F) AUTHORIZE THE VOLUNTARY DISSOLUTION OF THE CORPORATION OR REVOKE PROCEEDINGS THEREFOR; (G) ADOPT A PLAN FOR THE DISTRIBUTION OF THE ASSETS OF THE CORPORATION; (H) AMEND, ALTER, OR REPEAL ANY RESOLUTION OF THE MEMBERS OF THE CORPORATION; (I) INITIATE OR RESOLVE LITIGATION IN WHICH THE CORPORATION IS A PARTY IF THE LITIGATION OR RESOLUTION WOULD HAVE A MATERIAL ADVERSE EFFECT ON THE FINANCIAL WELL-BEING OR PUBLIC PERCEPTION OF THE CORPORATION OR ITS MEMBERS; (J) CHANGE THE FUNDAMENTAL PURPOSES OF THE CORPORATION; (K) ENTER INTO ANY NEW LINE OF BUSINESS; (L) OR AUTHORIZE THE RELOCATION FROM THE UNIVERSITY OF WASHINGTON MEDICAL CENTER TO ANOTHER HOSPITAL FACILITY OF THE TWENTY INPATIENT BEDS FOR WHICH THE CORPORATION HAS BEEN GRANTED A HOSPITAL LICENSE. FINALLY, THE FOLLOWING IS SUBJECT TO APPROVAL BY THE CORPORATION'S MEMBERS: - THE CORPORATION'S ANNUAL BUDGET - APPOINTMENT OF THREE ADDITIONAL DIRECTORS TO THE BOARD EXECUTIVE COMMITTEE (IN ADDITION TO THE CORPORATION'S CHAIR, IMMEDIATE PAST CHAIR, VICE CHAIR, TREASURER, AND SECRETARY) - APPOINTMENT OF DIRECTORS TO THE BOARD GOVERNANCE COMMITTEE - APPOINTMENT OF TWO DIRECTORS TO THE BOARD FINANCE COMMITTEE (IN ADDITION TO THE TREASURER) - SELECTION OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS TO CONDUCT AN ANNUAL FINANCIAL AUDIT OF THE CORPORATION FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 WAS PREPARED BY A PUBLIC ACCOUNTING FIRM AND INTERNALLY REVIEWED PRIOR TO PRESENTATION TO THE BOARD-APPOINTED FINANCE AND AUDIT COMMITTEE. THE FORM 990 WAS PROVIDED TO THE FINANCE AND AUDIT COMMITTEE FOR REVIEW BEFORE FILING. THE CHAIR OF THE FINANCE AND AUDIT COMMITTEE REPORTS TO THE FULL BOARD. ALL BOARD MEMBERS ARE PRESENTED WITH A COPY BEFORE FILING FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS ANNUALLY MONITORED THROUGH A QUESTIONNAIRE. IT IS A POLICY OF THE SCCA FOR SELF REPORTING. THIS SELF REPORTING IS APPLICABLE TO THE BOARD OF DIRECTORS AND ALL MANAGEMENT STAFF. THE DETERMINATION OF WHETHER AN ISSUE EXISTS IS MADE BY THE INTEGRITY OFFICER. THE ESCALATION PROCESS IS TO THE SENIOR MANAGEMENT TEAM, AND, IF DEEMED APPROPRIATE, TO THE BOARD OF DIRECTORS INTEGRITY COMMITTEE, BOARD OF DIRECTORS GOVERNANCE COMMITTEE, AND LEGAL COUNSEL. CONFLICTS OF INTEREST ARE ADDRESSED IF AND WHEN THEY ARISE. THE CONFLICTED BOARD MEMBER RECUSES HIM OR HERSELF FROM DISCUSSION AND VOTING ON THE MATTER. FORM 990, PART VI, SECTION B, LINE 15 AN INDEPENDENT COMPENSATION CONSULTING FIRM PERFORMS A MARKET ANALYSIS OF EXECUTIVE PAY AT COMPARABLE ORGANIZATIONS. A CONSULTANT FROM THIS FIRM PRESENTS ITS FINDINGS TO THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS EVERY TWO YEARS. THE ANALYSIS WAS LAST PERFORMED AND PRESENTED IN MAY OF 2011. IN THE INTERVENING YEARS, THE PRIOR YEAR'S MARKET ANALYSIS IS UPDATED USING AN APPROPRIATE INFLATION FACTOR FOR USE BY THE COMPENSATION COMMITTEE IN ITS ANNUAL REVIEW OF TOTAL COMPENSATION FOR THE OFFICERS. THE COMPENSATION COMMITTEE DOCUMENTS ITS MEETINGS AND DECISIONS IN A TIMELY MANNER. THE COMPENSATION COMMITTEE PROMPTLY REPORTS TO THE BOARD ALL ACTIONS TAKEN AND SIGNIFICANT ISSUES DISCUSSED AT ITS MEETINGS. FORM 990, PART VI, SECTION C, LINE 19 THE SCCA DOES NOT MAKE ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC. AS REQUIRED BY THE IRS, THE SCCA'S AUDITED FINANCIAL STATEMENTS ARE ATTACHED TO FORM 990, WHICH IS A PUBLIC DISCLOSURE DOCUMENT. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 1,264,055. PROCURE SEATTLE HOLDINGS, LLC - CHANGE IN VALUE -13,537,782. IMPAIRMENT LOSSES -29,469. ROUNDING 35. PROCURE SEATTLE HOLDINGS, LLC K-1 53. TOTAL TO FORM 990, PART XI, LINE 5: -12,303,108. PROCURE SEATTLE HOLDINGS LLC 192 LEXINGTON AVE FLOOR 4 NEW YORK NY 10016 270817057 PROTON BEAM THERAPY CENTER DE UNRELATED 0 37 24811028 0 0 0.19000